Product
GMA106
Aliases
GMA106 Injection, GMA106 Matching Placebo, Matching placebo for GMA106
1 clinical trial
1 indication
Indication
ObesityClinical trial
A PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF GMA106 IN HEALTHY, OVERWEIGHT AND OBESE ADULTSStatus: Completed, Estimated PCD: 2023-11-17